Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 7465-7466 [2013-02178]

Download as PDF Federal Register / Vol. 78, No. 22 / Friday, February 1, 2013 / Notices (NITRD) National Coordination Office (NCO) on January 29, 2013. Suzanne H. Plimpton, Reports Clearance Officer, National Science Foundation. [FR Doc. 2013–02188 Filed 1–31–13; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION [Docket No. NRC–2012–0217] Agency Information Collection Activities: Submission for the Office of Management and Budget (OMB) Review; Comment Request Nuclear Regulatory Commission. ACTION: Notice of the OMB review of information collection and solicitation of public comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has recently submitted to OMB for review the following proposal for the collection of information under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register notice with a 60-day comment period on this information collection on November 20, 2012 (77 FR 69663). 1. Type of submission, new, revision, or extension: Extension. 2. The title of the information collection: 10 CFR part 55, Operators’ Licenses. 3. Current OMB approval number: 3150–0018. 4. The form number if applicable: N/ A. 5. How often the collection is required: As necessary for NRC to meet its responsibilities to determine the eligibility for applicants and operators. 6. Who will be required or asked to report: Holders of, and applicants for facility (i.e., nuclear power and nonpower research and test reactor) operating licenses and individual operator licensees. 7. An estimate of the number of annual responses: 236. 8. The estimated number of annual respondents: 101. 9. An estimate of the total number of hours needed annually to complete the requirement or request: 165,900. 10. Abstract: Part 55 of Title 10 of the Code of Federal Regulations (10 CFR), srobinson on DSK4SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:26 Jan 31, 2013 Jkt 229001 ‘‘Operators’ Licenses,’’ specifies information and data to be provided by applicants and facility licensees so that the NRC may make determinations concerning the licensing and requalification of operators for nuclear reactors, as necessary to promote public health and safety. The reporting and recordkeeping requirements contained in 10 CFR part 55 are mandatory for the facility licensees and the applicants affected. The public may examine and have copied for a fee publicly available documents, including the final supporting statement, at the NRC’s Public Document Room, Room O–1F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20874. The OMB clearance requests are available at the NRC’s public Web site: http:// www.nrc.gov/public-involve/doccomment/omb/. The document will be available on the NRC’s home page site for 60 days after the signature date of this notice. Comments and questions should be directed to the OMB reviewer listed below by March 4, 2013. Comments received after this date will be considered if it is practical to do so, but assurance of consideration cannot be given to comments received after this date. Chad Whiteman, Desk Officer, Office of Information and Regulatory Affairs (3150–0018), NEOB–10202, Office of Management and Budget, Washington, DC 20503. Comments can also be emailed to Chad_S_Whiteman@omb.eop.gov or submitted by telephone at 202–395– 4718. The NRC Clearance Officer is Tremaine Donnell, 301–415–6258. Dated at Rockville, Maryland, this 22nd day of January, 2013. For the Nuclear Regulatory Commission. Tremaine Donnell, NRC Clearance Officer, Office of Information Services. [FR Doc. 2013–02151 Filed 1–31–13; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of SUMMARY: PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 7465 Isotopes (ACMUI) on March 5, 2013, to discuss the draft report of the ACMUI Rulemaking Subcommittee that was formed to provide comments to the NRC staff on the proposed changes to 10 CFR Part 35. Contingent upon the outcome of the March 5, 2013, the NRC will also convene a second teleconference of the ACMUI on March 12, 2013, to further discuss the ACMUI Rulemaking Subcommittee Report. A copy of the agenda for each meeting will be available at http://www.nrc.gov/readingrm/doc-collections/acmui/agenda. Handouts for each of the meetings will be available at http://www.nrc.gov/ reading-rm/doc-collections/acmui/ meeting-slides/. The agenda(s) and handouts may also by obtained by contacting Ms. Sophie Holiday using the information below. DATES: The teleconference meeting will be held on Tuesday, March 5, 2013, 2:00 p.m. to 5:00 p.m. Eastern Standard Time (EST). The second teleconference meeting will be held on Tuesday, March 12, 2013, 2:00 p.m. to 5:00 p.m. Eastern Standard Time (EST). Public Participation: Any member of the public who wishes to participate in the teleconference discussions should contact Ms. Holiday using the contact information below. Contact Information: Sophie Holiday, email: sophie.holiday@nrc.gov, telephone: (301) 415–7865. Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Holiday at the contact information listed above. All submittals must be received by February 28, three business days prior to the meeting, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meetings, at the discretion of the Chairman. 3. The transcript will be available on the ACMUI’s web site (http:// www.nrc.gov/reading-rm/doccollections/acmui/tr/) approximately 30 calendar days following the meeting, on April 5, 2013 and April 12, 2013. A meeting summary will be available approximately 30 business days following the meeting, on April 16, 2013 and April 23, 2013. The meetings will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section E:\FR\FM\01FEN1.SGM 01FEN1 7466 Federal Register / Vol. 78, No. 22 / Friday, February 1, 2013 / Notices 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. Dated: January 28, 2013. Andrew L. Bates, Advisory Committee Management Officer. BILLING CODE 7590–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. IC–30370] Notice of Applications for Deregistration Under Section 8(f) of the Investment Company Act of 1940 January 25, 2013. srobinson on DSK4SPTVN1PROD with NOTICES The following is a notice of applications for deregistration under section 8(f) of the Investment Company Act of 1940 for the month of January 2013. A copy of each application may be obtained via the Commission’s Web site by searching for the file number, or for an applicant using the Company name box, at http://www.sec.gov/search/ search.htm or by calling (202) 551– 8090. An order granting each application will be issued unless the SEC orders a hearing. Interested persons may request a hearing on any application by writing to the SEC’s Secretary at the address below and serving the relevant applicant with a copy of the request, personally or by mail. Hearing requests should be received by the SEC by 5:30 p.m. on February 19, 2013, and should be accompanied by proof of service on the applicant, in the form of an affidavit or, for lawyers, a certificate of service. Hearing requests should state the nature of the writer’s interest, the reason for the request, and the issues contested. Persons who wish to be notified of a hearing may request notification by writing to the Secretary, U.S. Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549–1090. FOR FURTHER INFORMATION CONTACT: Diane L. Titus at (202) 551–6810, SEC, Division of Investment Management, Office of Investment Company Regulation, 100 F Street NE., Washington, DC 20549–8010. Value Line U.S. Government Money Market Fund Inc. [File No. 811–2898] Summary: Applicant seeks an order declaring that it has ceased to be an investment company. The applicant has transferred its assets to Daily Income Fund and, on October 19, 2012, made a final distribution to its shareholders based on net asset value. Expenses of 17:26 Jan 31, 2013 Jkt 229001 Delaware Investments Global Dividend and Income Fund, Inc. [File No. 811– 8246] Summary: Applicant, a closed-end investment company, seeks an order declaring that it has ceased to be an investment company. The applicant has transferred its assets to Helios Total Return Fund Inc. and, on April 2, 2012, made a final distribution to its shareholders based on net asset value. Expenses of $375,151 incurred in connection with the reorganization were paid by applicant and the acquiring fund. Filing Date: The application was filed on December 26, 2012. Applicant’s Address: Three World Financial Center, 200 Vesey St., New York, NY 10281–1010. Summary: Applicant, a closed-end investment company, seeks an order declaring that it has ceased to be an investment company. Applicant has transferred its assets to Delaware Enhanced Global Dividend and Income Fund, and on October 5, 2011, applicant made a distribution to its shareholders based on net asset value. The Bank of New York Mellon is holding in escrow applicant’s remaining shares of the acquiring fund for the benefit of those former shareholders of applicant who have not turned in their physical share certificates. Expenses of approximately $233,975 incurred in connection with the reorganization were paid by applicant, the acquiring fund and Delaware Management Company, applicant’s investment adviser. Filing Date: The application was filed on November 20, 2012. Applicant’s Address: 2005 Market St., Philadelphia, PA 19103–7094. Foresight Funds Inc. [File No. 811– 21385] Man Long Short Fund [File No. 811– 22430] Summary: Applicant seeks an order declaring that it has ceased to be an investment company. On December 7, 2012, applicant made a liquidating distribution to its shareholders, based on net asset value. Expenses of $500 incurred in connection with the liquidation were paid by Foresight Asset Management, LLC, applicant’s investment adviser. Filing Date: The application was filed on December 18, 2012. Applicant’s Address: 1634 Pebble Chase Dr., Katy, TX 77450. Summary: Applicant, a closed-end investment company, seeks an order declaring that it has ceased to be an investment company. Applicant currently has fewer than 100 beneficial owners, is not presently making an offering of securities and does not propose to make any offering of securities. Applicant will continue to operate as a private investment fund in reliance on section 3(c)(1) of the Act until final payment in liquidation of its remaining assets. Filing Dates: The application was filed on November 13, 2012, and amended on January 4, 2013. Applicant’s Address: 452 Fifth Ave., 25th Floor, New York, NY 10018. Helios Strategic Mortgage Income Fund, Inc. [File No. 811–21102] [FR Doc. 2013–02178 Filed 1–31–13; 8:45 am] VerDate Mar<15>2010 $71,500 incurred in connection with the reorganization were paid by applicant. Filing Date: The application was filed on January 9, 2013. Applicant’s Address: 7 Times Sq., 21st Floor, New York, NY 10036. BlackRock Credit Allocation Income Trust I, Inc. [File No. 811–21341]; BlackRock Credit Allocation Income Trust III [File No. 811–21280] Summary: Each applicant, a closedend investment company, seeks an order declaring that it has ceased to be an investment company. The applicants have transferred their assets to BlackRock Credit Allocation Income Trust IV and, on December 10, 2012, made final distributions to their shareholders based on net asset value. Expenses of $219,798 and $247,780, respectively, incurred in connection with the reorganizations were paid by each applicant. Filing Date: The applications were filed on January 15, 2013. Applicants’ Address: 100 Bellevue Parkway, Wilmington, DE 19809. PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 Dividend Growth Trust [File No. 811– 9497] Summary: Applicant seeks an order declaring that it has ceased to be an investment company. The applicant has transferred its assets to a corresponding series of Goldman Sachs Trust and, on February 27, 2012, made a final distribution to its shareholders based on net asset value. Expenses of approximately $508,974 incurred in connection with the reorganization were paid by Goldman Sachs Asset Management, L.P., investment adviser to the acquiring fund, and Dividend Asset Capital, LLC (formerly Dividend Growth Advisors, LLC), investment adviser to the applicant. E:\FR\FM\01FEN1.SGM 01FEN1

Agencies

[Federal Register Volume 78, Number 22 (Friday, February 1, 2013)]
[Notices]
[Pages 7465-7466]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02178]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on March 5, 2013, to discuss the draft report of the 
ACMUI Rulemaking Subcommittee that was formed to provide comments to 
the NRC staff on the proposed changes to 10 CFR Part 35. Contingent 
upon the outcome of the March 5, 2013, the NRC will also convene a 
second teleconference of the ACMUI on March 12, 2013, to further 
discuss the ACMUI Rulemaking Subcommittee Report. A copy of the agenda 
for each meeting will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda. Handouts for each of the meetings will be 
available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-slides/. The agenda(s) and handouts may also by obtained by 
contacting Ms. Sophie Holiday using the information below.

DATES: The teleconference meeting will be held on Tuesday, March 5, 
2013, 2:00 p.m. to 5:00 p.m. Eastern Standard Time (EST). The second 
teleconference meeting will be held on Tuesday, March 12, 2013, 2:00 
p.m. to 5:00 p.m. Eastern Standard Time (EST).
    Public Participation: Any member of the public who wishes to 
participate in the teleconference discussions should contact Ms. 
Holiday using the contact information below.
    Contact Information: Sophie Holiday, email: sophie.holiday@nrc.gov, 
telephone: (301) 415-7865.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by February 28, three business days 
prior to the meeting, and must pertain to the topic on the agenda for 
the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meetings, at the discretion of the Chairman.
    3. The transcript will be available on the ACMUI's web site (http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) approximately 30 
calendar days following the meeting, on April 5, 2013 and April 12, 
2013. A meeting summary will be available approximately 30 business 
days following the meeting, on April 16, 2013 and April 23, 2013.
    The meetings will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section

[[Page 7466]]

161a); the Federal Advisory Committee Act (5 U.S.C. App); and the 
Commission's regulations in Title 10, U.S. Code of Federal Regulations, 
Part 7.

    Dated: January 28, 2013.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2013-02178 Filed 1-31-13; 8:45 am]
BILLING CODE 7590-01-P